Cyrus Gill
Executive Chair
Why I’m Passionate About Unifying Patients and Research:
I am deeply committed to connecting patients with clinical trials that could improve their treatment outcomes. The integrity of the IRB review is foundational to public trust in research, and I am motivated by ensuring that studies are ethically justified, scientifically sound, and reviewed in a manner that supports appropriate access to research while maintaining meaningful human subject protections.
Cyrus (Cy) Gill is an experienced clinical research professional who brings decades of experience to his role of overseeing compliance human research protections here at Univo Institutional Review Board (IRB).
As the Executive Chair at Univo IRB, he oversees the IRB, Institutional chairs, manages board agendas, and ensures compliance with regulatory standards for full and expedited reviews, as well as exempt determinations. Cy represents Univo IRB during regulatory inspections, AAHRPP site visits, and customer audits. He is also responsible for appointing new board members and making final decisions regarding their selection. His leadership extends to providing ongoing guidance and continuing education to IRB members, ensuring alignment with evolving regulations, AAHRPP standards, and OHRP / FDA guidance.
In his role as Executive Chair, Cy oversees IRB and institutional chairs, manages board agendas, and leads the review of full board, expedited, and exempt submissions. He represents Univo IRB during regulatory inspections, AAHRPP site visits, and customer audits. He is also responsible for appointing new board members and making final decisions regarding their selection. His leadership extends to providing ongoing guidance and continuing education to IRB members, ensuring alignment with evolving regulations, AAHRPP standards, and OHRP / FDA guidance.
Over his career, he served on two central IRBs contributing to board decisions on a wide range of research. Additionally, Cy has held clinical operations leadership roles for Sponsors and CROs in biotech, pharmaceutical, and medical device/IVD companies. Cy completed a Fellowship in Bioethics at Harvard Medical School, further grounding his IRB leadership in contemporary ethical frameworks, participant centered consent considerations, and emerging issues in clinical research oversight. He also holds a Master of Business Administration, a Master of Science in Clinical Research Management, and holds multiple certifications from the Association of Clinical Research Professionals, including Certified Project Manager, Certified Medical Device Professional, and Certified Clinical Research Associate.
His combined background in clinical operations, bioethics, and IRB leadership supports a balanced approach to research oversight that centers participant protection while facilitating responsible, compliant clinical research intended to advance medical knowledge and improve health outcomes.
Back to Team